ESSA Pharma removes Class A preferred share rights from articles; no shares outstanding

ESSA Pharma Inc.

Amended Articles of Incorporation on Sept 14, 2023 to remove special rights attached to Class A preferred shares.
No Class A preferred shares are issued or outstanding.
Amendment is a procedural cleanup; no impact on capital structure or voting rights.
Amended articles filed as Exhibit 3.1 to the 8-K.

Key facts

Extracted from this filing and checked against the source text.

Governance Changes SEC 8-K Item 5.03/5.05/5.06 confidence 0.9

ESSA Pharma Inc.: Removed special rights and restrictions on Class A preferred shares from Articles of Incorporation (effective 2023-09-14).

Change: charter amendment
Effective: 2023-09-14

Exact text from the filing

On September 14, 2023, ESSA Pharma inc. (the “Company”) amended its Articles of Incorporation (the “Articles of Incorporation”) to remove the special rights and restrictions attached to the Class “A” preferred shares in the capital of the Company (none of which are issued and outstanding) under Article 30 of the Articles of Incorporation (the “Articles Amendment”).

View on SEC.gov

Browse all governance changes →

Source: SEC EDGAR

accession 0001279569-23-001203

view filing index on sec.gov

view primary document

Machine-readable: JSON · Markdown · Plain text

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.